Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19?
고등급 B 세포 림프종을 가진 허약한 환자에서 R-CHOP의 한 주기 또는 연장된 COVID-19에 대한 완전한 반응?
Meta-Analysis
[키워드] (Polymerase Chain Reaction
age
aggressive behavior
Antitumor
Antitumor effect
B cell
B-cell
B-cell lymphoma
chain
Chain Reaction
Chemotherapy
CHOP
clinically
Complete
COVID
COVID-19
COVID-19 infection
COVID-19 PCR test
Cyclophosphamide
death
diagnosed
Diagnosis
discharged
emergency department
emission
fatigue
Favipiravir
female
Fever
Hematologic malignancy
Hematological malignancies
high risk
High-grade
High-grade lymphoma
highlight
hospital
Hospitalization
increase
Infection
Infectious disease
Infectious diseases
Ki-67
lymphoma
lymphomas
malignancy
Meta-analysis
mitotic
mitotic index
morphologically
Mortality
Older
oncology
Oncolytic effect
oncolytic virus
Patient
patient with SARS-CoV-2
patients
PCR
PCR test
polymerase chain reaction
positive
Positron
positron emission
Positron emission tomography
Prednisolone
proliferation
Prolonged
Prolonged COVID.
reaction
receiving
reduced
referred to
reported
risk of death
rituximab
SARS-COV-2 infection
significantly higher
survival
the patient
therapy
transferred
Treatment
vincristine
[DOI] 10.1053/j.seminoncol.2021.11.001 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1053/j.seminoncol.2021.11.001 PMC 바로가기 [Article Type] Meta-Analysis